Literature DB >> 10503935

Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure.

M Hou1, M Malmsjö, S Möller, E Pantev, A Bergdahl, X H Zhao, X Y Sun, T Hedner, L Edvinsson, D Erlinge.   

Abstract

We wanted to study the expression of P2-receptors at the mRNA-level in the heart and if it is affected by congestive heart failure (CHF). To quantify the P2 receptor mRNA-expression we used a competitive RT-PCR protocol which is based on an internal RNA standard. The P2 receptor mRNA-expression was quantified in hearts from CHF rats and compared to sham-operated rats. Furthermore, the presence of receptor mRNA was studied in the myocardium from patients with heart failure. In the sham operated rats the G-protein coupled P2Y-receptors were expressed at a higher level than the ligand gated ion-channel receptor (P2X1). Among the P2Y-receptors the P2Y6-receptor was most abundantly expressed (P2Y6 > P2Y1 > P2Y2 = P2Y4 > P2X1). A prominent change was seen for the P2X1- and P2Y2-receptor mRNA levels which were increased 2.7-fold and 4.7-fold respectively in the myocardium from the left ventricle of CHF-rats. In contrast, the P2Y1-, P2Y4- and P2Y6-receptor mRNA levels were not significantly altered in CHF rats. In human myocard the P2X1-, P2Y1-, P2Y2-, P2Y6- and P2Y11-receptors were detected by RT-PCR in both right and left atria and ventricles, while the P2Y4-receptor band was weak or absent. In conclusion, most of the studied P2-receptors were expressed in both rat and human hearts. Furthermore, the P2X1- and P2Y2-receptor mRNA were upregulated in CHF, suggesting a pathophysiological role for these receptors in the development of heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503935     DOI: 10.1016/s0024-3205(99)00353-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  17 in total

1.  Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction.

Authors:  Harjot K Saini; Qiming Shao; Sorin Musat; Nobuakira Takeda; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  Involvement of UTP in protection of cardiomyocytes from hypoxic stress.

Authors:  Asher Shainberg; Smadar Yitzhaki; Or Golan; Kenneth A Jacobson; Edith Hochhauser
Journal:  Can J Physiol Pharmacol       Date:  2009-04       Impact factor: 2.273

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 4.  Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective.

Authors:  C G Dos Remedios; A Li; S Lal
Journal:  Biophys Rev       Date:  2018-07-18

5.  Purinergic receptors expressed in human skeletal muscle fibres.

Authors:  A Bornø; T Ploug; L T Bune; J B Rosenmeier; P Thaning
Journal:  Purinergic Signal       Date:  2011-11-04       Impact factor: 3.765

6.  Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress.

Authors:  Smadar Yitzhaki; Vladimir Shneyvays; Kenneth A Jacobson; Asher Shainberg
Journal:  Biochem Pharmacol       Date:  2005-04-15       Impact factor: 5.858

7.  P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions.

Authors:  Hanny Musa; James O Tellez; Natalie J Chandler; Ian D Greener; Michał Maczewski; Urszula Mackiewicz; Andrzej Beresewicz; Peter Molenaar; Mark R Boyett; Halina Dobrzynski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-21       Impact factor: 3.000

8.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors.

Authors:  Liaman K Mamedova; Bhalchandra V Joshi; Zhan-Guo Gao; Ivar von Kügelgen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

9.  Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction.

Authors:  Anna-Karin Wihlborg; Johanna Balogh; Lingwei Wang; Catharina Borna; Ying Dou; Bhalchandra V Joshi; Eduardo Lazarowski; Kenneth A Jacobson; Anders Arner; David Erlinge
Journal:  Circ Res       Date:  2006-03-16       Impact factor: 17.367

10.  Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts.

Authors:  Amarnath Talasila; Renée Germack; John M Dickenson
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.